Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia [PDF]
Houshmand, Mohammad, Saglio, Giuseppe
core
Mechanistic Insights into Alternative Gene Splicing in Oxidative Stress and Tissue Injury. [PDF]
Dery KJ +3 more
europepmc +1 more source
Giant aortic aneurysm due to fibulin- 4 deficiency: case series. [PDF]
Sülü A, Başpınar O, Şahin DA.
europepmc +1 more source
On the low reproducibility of cancer studies. [PDF]
Wen H, Wang HY, He X, Wu CI.
europepmc +1 more source
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response. [PDF]
Warfvinge R +10 more
europepmc +1 more source
Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells. [PDF]
Kim DS +4 more
europepmc +1 more source
Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy. [PDF]
Chomel JC, Turhan AG.
europepmc +1 more source
Related searches:
Following the discovery of the p210bcrabl protein product of the bcrabl chimeric fusion gene generated by the Philadelphia chromosome translocation in chronic myelogenous leukemia (CML), structure function studies quickly identified which parts of this molecule were playing a role in the generation of the phenotypes of growth factor independent growth,
X Y, Guo +3 more
openaire +4 more sources
A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance [PDF]
Laurie L Parker
exaly +2 more sources
The t(9,22) chromosomal translocation generating the Philadelphia chromosome and the BCRABL oncogene has been shown both cytogenetically and molecularly to be the etiologic event in chronic myelogenous leukemia (CML). We have designed a ribozyme to cleave the BCRABL mRNA by targeting a GUU triplet adjacent to the junction of the c-BCR and c-ABL fused ...
S K, Shore, P M, Nabissa, E P, Reddy
openaire +1 more source

